SRE:NYSE

DBA Sempra

Data as of 2026-03-10 - not real-time

$93.51

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Sempra is trading well above its longer‑term moving averages, with the 20‑day SMA sitting above both the 50‑day and 200‑day levels, indicating a bullish price momentum. The RSI sits near the midpoint, while the MACD histogram is modestly negative, suggesting short‑term pressure but no imminent reversal. Fundamentally, the stock carries a price multiple that markedly exceeds the sector average, and a discounted cash flow model points to a fair value dramatically lower than the current market price. The dividend yield is appealing, yet the payout ratio is close to full earnings and free cash flow is deeply negative, raising concerns about dividend sustainability. High leverage and a substantial debt‑to‑equity ratio further underscore balance‑sheet risk, even as the utility sector generally offers low beta and defensive characteristics. Recent earnings beat estimates, though revenue slipped year‑over‑year, and the stock has enjoyed strong weekly momentum amid an “extreme greed” market sentiment.
Overall, the combination of technical bullishness, overvaluation, heavy debt, and dividend sustainability questions suggests caution. Investors may capture short‑term upside on momentum, but the long‑term outlook is tempered by valuation disconnect and financial strain.

Trading Recommendations

Short Term

< 1 year
buy
Conviction: 7/10

Key Factors

  • Technical momentum above key moving averages
  • Recent earnings beat providing short‑term catalyst
  • Attractive dividend yield despite sustainability concerns

Medium Term

1–3 years
hold
Conviction: 5/10

Key Factors

  • Significant overvaluation relative to fundamentals
  • High leverage and negative free cash flow
  • Sector defensive nature offering some stability

Long Term

> 3 years
sell
Conviction: 4/10

Key Factors

  • Valuation far above DCF fair value
  • Unsustainable dividend payout and cash‑flow weakness
  • Elevated debt levels increasing financial risk

Key Metrics & Analysis

Financial Health

Revenue Growth-0.20%
Profit Margin13.40%
P/E Ratio34.0
ROE5.19%
ROA1.77%
Debt/Equity83.39
P/B Ratio1.9
Op. Cash Flow$4.6B
Free Cash Flow$-27727874048
Industry P/E20.8

Technical Analysis

TrendBullish
RSI54.7
Support$86.18
Resistance$97.45
MA 20$93.36
MA 50$90.17
MA 200$85.65
MACDBearish
VolumeStable
Fear & Greed Index75.89

Valuation

Fair Value$14.05
Target Price$101.50
Upside/Downside8.54%
GradeOvervalued
TypeValue
Dividend Yield2.81%

Risk Assessment

Beta0.62
Volatility17.10%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies. Not financial advice. Always do your own research before making any investment decisions.